Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2006 2
2007 8
2008 2
2009 2
2010 6
2011 1
2013 8
2014 12
2015 5
2016 6
2017 7
2018 12
2019 9
2020 5
2021 10
2022 9
2023 10
2024 6
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing.
Liu H, Li X, Zhang C, Hao X, Cao Y, Wang Y, Zhuang H, Yu N, Huang T, Liu C, Cao H, Lu Z, Song J, Liu L, Wang H, Li Z, Tang W. Liu H, et al. Among authors: song j. Adv Sci (Weinh). 2024 Oct;11(39):e2402115. doi: 10.1002/advs.202402115. Epub 2024 Aug 20. Adv Sci (Weinh). 2024. PMID: 39162005 Free PMC article.
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.
Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J, Zhang H, Zhao J, Yao A, Wu X, Wu C, Ji G, Liu X, Zhu F, Qin L, Xiao X, Deng Z, Kong X, Li S, Yu Y, Xi W, Deng W, Qi C, Liu H, Pu L, Wang P, Wang X. Xia Y, et al. Among authors: song j. J Immunother Cancer. 2022 Apr;10(4):e004656. doi: 10.1136/jitc-2022-004656. J Immunother Cancer. 2022. PMID: 35379737 Free PMC article. Clinical Trial.
Phosphorus-32 microspheres: A dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and Anti-PD1 immunotherapy potentiation.
Dai S, Su X, Li Z, Wang H, Liu L, Xie Y, Chai Y, Chen Y, Zhao Z, Luo B, Kong J, He Y, Cao H, Xin M, Shao G, Shi Y, Xiong F, Tang W, Song J. Dai S, et al. Among authors: song j. Mater Today Bio. 2025 Aug 16;34:102210. doi: 10.1016/j.mtbio.2025.102210. eCollection 2025 Oct. Mater Today Bio. 2025. PMID: 40893370 Free PMC article.
Site-specific template generative approach for retrosynthetic planning.
Shee Y, Li H, Zhang P, Nikolic AM, Lu W, Kelly HR, Manee V, Sreekumar S, Buono FG, Song JJ, Newhouse TR, Batista VS. Shee Y, et al. Among authors: song jj. Nat Commun. 2024 Sep 6;15(1):7818. doi: 10.1038/s41467-024-52048-4. Nat Commun. 2024. PMID: 39251606 Free PMC article.
PD-L1 Blockade with Biodegradable Envafolimab-Loaded Microspheres Synergizes with Transarterial Chemoembolization to Overcome Myeloid-Derived Suppressor Cell-Driven Immune Escape in Hepatocellular Carcinoma.
Liu H, Huang J, Wang Z, Wang N, Hao X, Chai Y, Yu N, Cao H, He Y, Dai S, Xu J, Zhang Z, Kong J, Xiong F, Tang W, Song J. Liu H, et al. Among authors: song j. ACS Appl Mater Interfaces. 2026 Jan 28;18(3):4979-4994. doi: 10.1021/acsami.5c24260. Epub 2026 Jan 18. ACS Appl Mater Interfaces. 2026. PMID: 41548132 Free PMC article.
124 results